Stephan Richter Selected Research

Margins of Excision

1/2022

Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Richter Research Topics

Disease

8	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2013
5	Neoplasms (Cancer) 01/2022 - 01/2018
3	Multiple Sclerosis 09/2021 - 05/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2004 - 01/2004
2	Relapsing-Remitting Multiple Sclerosis 01/2022 - 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Margins of Excision 01/2022
1	Ulcerative Colitis 01/2022
1	Hemangiosarcoma (Angiosarcoma) 03/2021
1	Liver Failure 03/2021
1	Neutropenia 10/2020
1	Febrile Neutropenia 10/2020
1	Testicular Neoplasms (Testicular Cancer) 02/2020
1	Pain (Aches) 01/2020
1	Anorexia 01/2020
1	Cachexia 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 05/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2019
1	Chordoma 01/2019
1	Alveolar Rhabdomyosarcoma 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2016
1	Cardiotoxicity 01/2016
1	Heart Failure 01/2016
1	Leiomyosarcoma 01/2014
1	Myocardial Infarction 01/2013

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
3	pazopanib FDA Link 01/2022 - 10/2020
2	Alemtuzumab (Campath)FDA Link 01/2021 - 05/2019
2	TrabectedinIBA 01/2020 - 01/2013
2	AnthracyclinesIBA 01/2016 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 06/2004 - 01/2004
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	glucarpidaseIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	ozanimodIBA 01/2022
1	Cladribine FDA LinkGeneric 09/2021
1	TabletsIBA 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	cabazitaxel FDA Link 02/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	olaparibIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	CrizotinibIBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2016
1	Gemcitabine FDA Link 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	X-Linked Inhibitor of Apoptosis ProteinIBA 06/2004
1	SurvivinIBA 06/2004
1	Apoptosis Regulatory ProteinsIBA 03/2004
1	Inhibitor of Apoptosis ProteinsIBA 01/2004

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2004
2	Palliative Care (Palliative Therapy) 01/2020 - 01/2017
1	Aftercare (After-Treatment) 01/2022
1	Radiotherapy 01/2022
1	Neoadjuvant Therapy 01/2013
1	Drug Therapy (Chemotherapy) 06/2004